InvestorsHub Logo

dmlcento

02/17/20 2:03 PM

#246828 RE: bfost #246826

Bfost, do you really think that 20-40% of primary care docs are familiar with V? I would have to think that number is way lower than that.

jessellivermore

02/17/20 4:30 PM

#246848 RE: bfost #246826

bfost....

No point in disputing your numbers...

One thing which is different is there is very likely more doctors who put themselves on V than any other drug on the market, that is not Viagra. And those who do also put their patients on V (Vascepa / not Viagra ":>)...

I don't know whether you are on Vascepa...But more than likely you should be..prevention....

":>) JL

dockside130

02/17/20 8:06 PM

#246887 RE: bfost #246826

Bfost, I agree with your numbers. I am getting emails frequently advertising Vascepa. I do not see drug reps. I believe primary care docs are hearing from AMRN. My company does not allow drug reps in the office.

sts66

02/18/20 2:44 PM

#246982 RE: bfost #246826

If your numbers are anywhere close to being accurate, and we have no way to confirm them AFAIK (AMRN did some survey, forget what it was for exactly), but if they are something is seriously wrong - scrips should be double what they are right now IMO, especially the 80% awareness of cardios - somebody mentioned that even if you've had an MI you'll only see your cardio once a year, but that means those cardios know about a drug that can decrease their patient's risk of a CVE by a whopping -25% but they're not going to inform the patient about it until a normally scheduled appt. - sounds almost like malpractice to me.